I did a quick look at the company and think I'll pass for now a link to their slide presentation. Altus tried to get a recombinant pancreatic insufficiency drug and failed. As I recall their from Science Officer (and I think a founder), Alex Margolin bought the rights to the drug started a new company with it and sold it to someone who also failed.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.